Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Cash from Financing Activities: 2020-2024

Historic Cash from Financing Activities for Bright Minds Biosciences (DRUG) over the last 5 years, with Sep 2024 value amounting to $595,934.

  • Bright Minds Biosciences' Cash from Financing Activities fell 101.11% to -$7,706 in Q3 2021 from the same period last year, while for Sep 2021 it was $20.5 million, marking a year-over-year change of. This contributed to the annual value of $595,934 for FY2024, which is 63.31% down from last year.
  • Bright Minds Biosciences' Cash from Financing Activities amounted to $595,934 in FY2024, which was down 63.31% from $1.6 million recorded in FY2023.
  • In the past 5 years, Bright Minds Biosciences' Cash from Financing Activities ranged from a high of $20.6 million in FY2021 and a low of $595,934 during FY2024.
  • Over the past 3 years, Bright Minds Biosciences' median Cash from Financing Activities value was $1.6 million (recorded in 2023), while the average stood at $2.1 million.
  • In the last 5 years, Bright Minds Biosciences' Cash from Financing Activities spiked by 2,648.18% in 2021 and then slumped by 80.26% in 2022.
  • Bright Minds Biosciences' Cash from Financing Activities (Yearly) stood at $750,172 in 2020, then spiked by 2,648.18% to $20.6 million in 2021, then slumped by 80.26% to $4.1 million in 2022, then tumbled by 60.10% to $1.6 million in 2023, then slumped by 63.31% to $595,934 in 2024.